Laron Syndrome - From Man to Mouse Lessons from Clinical and Experimental Experience /

Laron syndrome (LS), or primary growth hormone (GH) insensitivity, was first described in 1966. Since then, many patients worldwide have been diagnosed with LS, which involves defects in the GH receptor that cause combined congenital deficiency of GH and IGF-I activities. In this comprehensive book...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Laron, Zvi (Επιμελητής έκδοσης), Kopchick, J. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03383nam a22005415i 4500
001 978-3-642-11183-9
003 DE-He213
005 20151125151215.0
007 cr nn 008mamaa
008 101125s2011 gw | s |||| 0|eng d
020 |a 9783642111839  |9 978-3-642-11183-9 
024 7 |a 10.1007/978-3-642-11183-9  |2 doi 
040 |d GrThAP 
050 4 |a RJ1-570 
072 7 |a MJW  |2 bicssc 
072 7 |a MED069000  |2 bisacsh 
082 0 4 |a 618.92  |2 23 
245 1 0 |a Laron Syndrome - From Man to Mouse  |h [electronic resource] :  |b Lessons from Clinical and Experimental Experience /  |c edited by Zvi Laron, J. Kopchick. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2011. 
300 |a XIV, 531 p. 447 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a From the Content: Part I - Laron Syndrome in Man -- Clinical Aspects -- History of the Israeli Cohort of Laron Syndrome Patients -- Early Investigations -- Clinical Evidence of Growth Hormone Resistance in Patients with Laron Syndrome -- Diagnosis of Laron Syndrome -- Genetic Aspects -- Clinical Evaluation -- Perinatal Evaluation -- Perinatal Development ;Laron Syndrome -- Linear Growth Pattern of Untreated Laron Syndrome Patients -- Head Shape, Size and Growth of Untreated Patients with Laron Syndrome -- Sexual Development in Patients with Laron Syndrome. 
520 |a Laron syndrome (LS), or primary growth hormone (GH) insensitivity, was first described in 1966. Since then, many patients worldwide have been diagnosed with LS, which involves defects in the GH receptor that cause combined congenital deficiency of GH and IGF-I activities. In this comprehensive book the authors draw upon 50 years of multidisciplinary clinical and investigative follow-up of the large Israeli cohort of LS patients. The genetic basis of the syndrome is fully considered, and all aspects of the pathophysiology of IGF-I deficiency are described. Data derived from the recently generated mouse model of LS are reviewed and compared with the human LS experience. Valuable advice is provided on treatment, and treatment effects, such as metabolic effects, adipose tissue alterations, and impact on aging, are fully explored. Together, this book condenses, consolidates, compares, and contrasts data derived from the human and mouse LS experiences and provides a unique resource for clinical and basic scientists to evaluate and compare IGF-I and GH actions. 
650 0 |a Medicine. 
650 0 |a Human genetics. 
650 0 |a Human physiology. 
650 0 |a Molecular biology. 
650 0 |a Internal medicine. 
650 0 |a Endocrinology. 
650 0 |a Pediatrics. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Pediatrics. 
650 2 4 |a Endocrinology. 
650 2 4 |a Internal Medicine. 
650 2 4 |a Human Genetics. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Human Physiology. 
700 1 |a Laron, Zvi.  |e editor. 
700 1 |a Kopchick, J.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642111822 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-11183-9  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)